Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
QMRO Home
Blizard Institute
Centre for Genomics and Child Health
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
QMRO Home
Blizard Institute
Centre for Genomics and Child Health
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
Volume
133
Pagination
1865 - 1875
DOI
10.1182/blood-2018-08-868893
Journal
BLOOD
Issue
17
ISSN
0006-4971
Metadata
Show full item record
Authors
Howard, J; Hemmaway, CJ; Telfer, P; Layton, DM; Porter, J; Awogbade, M; Mant, T; Gretler, DD; Dufu, K; Hutchaleelaha, A
URI
https://qmro.qmul.ac.uk/xmlui/handle/123456789/65448
Collections
Centre for Genomics and Child Health
[835]